Artemis Acquisition registered with the SEC to offer 20 million units at $10 each. A unit consists of one share of Class A common stock and one-third of a warrant.
The new SPAC will be focusing on the healthcare or healthcare related industries in the United States and Europe.
Chairman and CEO Stephen Wiggins operates solely-owned investment vehicles Wiggins Ventures, and Wiggins Holdings.
Cantor is sole book-running manager of the offering. The underwriters have an over-allotment option to purchase up to 3 million additional units.
The SPAC has applied to list on the Nasdaq under ARACU. Read more.
